Logo image of KAVL

KAIVAL BRANDS INNOVATIONS GR (KAVL) Stock Fundamental Analysis

NASDAQ:KAVL - Nasdaq - US4831044023 - Common Stock - Currency: USD

0.5406  +0 (+0.11%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to KAVL. KAVL was compared to 17 industry peers in the Distributors industry. KAVL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. KAVL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

KAVL had negative earnings in the past year.
In the past year KAVL has reported a negative cash flow from operations.
KAVL had negative earnings in 4 of the past 5 years.
In the past 5 years KAVL reported 4 times negative operating cash flow.
KAVL Yearly Net Income VS EBIT VS OCF VS FCFKAVL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

KAVL has a worse Return On Assets (-63.05%) than 88.24% of its industry peers.
KAVL has a worse Return On Equity (-70.20%) than 76.47% of its industry peers.
Industry RankSector Rank
ROA -63.05%
ROE -70.2%
ROIC N/A
ROA(3y)-72.37%
ROA(5y)-40.78%
ROE(3y)-93.34%
ROE(5y)-49.66%
ROIC(3y)N/A
ROIC(5y)N/A
KAVL Yearly ROA, ROE, ROICKAVL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 150

1.3 Margins

With a decent Gross Margin value of 41.52%, KAVL is doing good in the industry, outperforming 76.47% of the companies in the same industry.
In the last couple of years the Gross Margin of KAVL has grown nicely.
The Profit Margin and Operating Margin are not available for KAVL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y23.05%
GM growth 5YN/A
KAVL Yearly Profit, Operating, Gross MarginsKAVL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

4

2. Health

2.1 Basic Checks

KAVL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, KAVL has more shares outstanding
Compared to 5 years ago, KAVL has more shares outstanding
Compared to 1 year ago, KAVL has an improved debt to assets ratio.
KAVL Yearly Shares OutstandingKAVL Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
KAVL Yearly Total Debt VS Total AssetsKAVL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of -2.97, we must say that KAVL is in the distress zone and has some risk of bankruptcy.
KAVL has a Altman-Z score of -2.97. This is amonst the worse of the industry: KAVL underperforms 82.35% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that KAVL is not too dependend on debt financing.
KAVL has a better Debt to Equity ratio (0.00) than 70.59% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.97
ROIC/WACCN/A
WACC15.46%
KAVL Yearly LT Debt VS Equity VS FCFKAVL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

A Current Ratio of 3.42 indicates that KAVL has no problem at all paying its short term obligations.
With a decent Current ratio value of 3.42, KAVL is doing good in the industry, outperforming 70.59% of the companies in the same industry.
A Quick Ratio of 3.42 indicates that KAVL has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 3.42, KAVL belongs to the best of the industry, outperforming 82.35% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.42
Quick Ratio 3.42
KAVL Yearly Current Assets VS Current LiabilitesKAVL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 58.25% over the past year.
KAVL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -71.85%.
Measured over the past years, KAVL shows a very negative growth in Revenue. The Revenue has been decreasing by -51.07% on average per year.
EPS 1Y (TTM)58.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.46%
Revenue 1Y (TTM)-71.85%
Revenue growth 3Y-51.07%
Revenue growth 5YN/A
Sales Q2Q%-93.69%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KAVL Yearly Revenue VS EstimatesKAVL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 20M 40M 60M 80M
KAVL Yearly EPS VS EstimatesKAVL Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 0 -2 -4 -6 -8

0

4. Valuation

4.1 Price/Earnings Ratio

KAVL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KAVL Price Earnings VS Forward Price EarningsKAVL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KAVL Per share dataKAVL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1 -1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for KAVL!.
Industry RankSector Rank
Dividend Yield N/A

KAIVAL BRANDS INNOVATIONS GR

NASDAQ:KAVL (6/13/2025, 10:18:55 AM)

0.5406

+0 (+0.11%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryDistributors
Earnings (Last)03-17 2025-03-17
Earnings (Next)06-16 2025-06-16
Inst Owners1.5%
Inst Owner Change13.77%
Ins Owners20.24%
Ins Owner Change0%
Market Cap6.24M
Analysts82.86
Price TargetN/A
Short Float %0.41%
Short Ratio0.45
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.61
P/FCF N/A
P/OCF N/A
P/B 0.49
P/tB 2.9
EV/EBITDA N/A
EPS(TTM)-1.58
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS0.34
BVpS1.1
TBVpS0.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -63.05%
ROE -70.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.52%
FCFM N/A
ROA(3y)-72.37%
ROA(5y)-40.78%
ROE(3y)-93.34%
ROE(5y)-49.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y23.05%
GM growth 5YN/A
F-Score5
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.42
Quick Ratio 3.42
Altman-Z -2.97
F-Score5
WACC15.46%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.46%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-71.85%
Revenue growth 3Y-51.07%
Revenue growth 5YN/A
Sales Q2Q%-93.69%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y13.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y47.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y47.62%
OCF growth 3YN/A
OCF growth 5YN/A